Investindustrial, a leading European group in the field of private equity, has signed an agreement through one of its investment vehicles for the entry of QuattroR into the capital of Medical Technology and Devices Group. MTD is an international group active in the design and manufacture of medical devices for home and professional care. Investindustrial […]
NLS Pharmaceutics, a Swiss clinical-stage biopharmaceutical company, has entered into a definitive agreement with BVF PARTNERS to raise aggregate gross proceeds of up to USD 30.0 million in a two-tranche private placement. The net proceeds will
Tandem Diabetes Care, a global insulin delivery and diabetes technology company, has announced that it has entered into a definitive agreement to acquire AMF Medical, the privately held Swiss developer of the Sigi™ Patch Pump,
The global innovation leader with technology-based materials and solutions, DuPont has divested the majority of its former Mobility & Materials segment to Celanese for a purchase price of $11 billion in cash, subject to customary transaction
As we have informed here last 10 November 2022, the clinical-stage biotechnology company Anokion has closed an USD 35 million equity investment from Pfizer through the Pfizer Breakthrough Growth Initiative. The Biotech company is focus on the treating
SWITCH, a Swiss foundation that has been the operator of the Swiss academic network of universities since 1987, is working with Phoenix Systems as part of a strategic partnership to implement and operate the SWITCH Cloud.
The Swiss-based integrated European energy company MET Group has formed a Swiss joint venture company Keppel MET Renewables with Keppel Infrastructure Holdings to pursue renewable energy opportunities in Western Europe. Keppel Infrastructure Holding is a
Wenger Vieli has advised the lead investor Redalpine Opportunity Fund on all Swiss legal aspects on the closing of Carvolution’s series D financing round. Redalpine is a seed and early-stage venture investor. Car subscription
Unilabs, a renowned diagnostic services provider, and RIMED, a recognised Swiss diagnostic radiology group, announced early November a unique partnership that will enable patients and referring facilities in Switzerland to benefit even more from integrated
Walder Wyss has advised BC Platforms, an expert of data science solutions for personalized healthcare, drug discovery and life science research, in connection with the CHF 20 million (approx. USD 20 million) growth financing round. This growth
